EN
instrument_fundamentals
| date | Close | change | Change (%) | instr__open | High | Low |
|---|
News
Geode Capital Management LLC Has $44.25 Million Stake in Novavax, Inc. (NASDAQ:NVAX)
Novavax, Inc. (NASDAQ:NVAX) Given Average Rating of "Hold" by Analysts
Wellington Management Group LLP Acquires New Holdings in Novavax, Inc. (NASDAQ:NVAX)
Novavax adjusts vaccine deal with Australian government By Investing.com
Novavax: Australia Cancels Delivery of Some COVID-19 Doses
Novavax says Australia cancels delivery of some Covid-19 doses
Novavax is as protective as other Covid vaccines, but has fewer side effects | Vox
Tidal Investments LLC Has $6.32 Million Stake in Novavax, Inc. (NASDAQ:NVAX)
Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50M Milestone By Investing.com
Novavax achieves $50M milestone in Sanofi partnershi By Investing.com
XTX Topco Ltd Boosts Holdings in Novavax, Inc. (NASDAQ:NVAX)
HC Wainwright Reaffirms “Buy” Rating for Novavax (NASDAQ:NVAX)
H.C. Wainwright reiterates Buy on Novavax stock as Phase 3 CIC trial begins By Investing.com
NVAX Starts Late-Stage Study on COVID-19-Flu Combo & Flu Vaccines - December 11, 2024 - Zacks.com
FDA Grants Fast Track Tag to SNY's Two COVID & Flu Vaccine Candidates - December 11, 2024 - Zacks.com
Novavax starts Phase 3 trial for dual COVID-19/flu vaccine By Investing.com
Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza By Investing.com
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - December 10, 2024 - Zacks.com
Two Sigma Advisers LP Has $25.25 Million Stake in Novavax, Inc. (NASDAQ:NVAX)
BNP Paribas Financial Markets Cuts Stock Holdings in Novavax, Inc. (NASDAQ:NVAX)
Novavax (NASDAQ:NVAX) Trading Up 10.1% - Time to Buy?
Stock Traders Purchase High Volume of Call Options on Novavax (NASDAQ:NVAX)
Brokerages Set Novavax, Inc. (NASDAQ:NVAX) Target Price at $17.83
Investors Purchase High Volume of Novavax Call Options (NASDAQ:NVAX)
Novavax to Sell Czech Manufacturing Plant to Novo Nordisk for $200M - December 5, 2024 - Zacks.com
Novavax sells Czech facility to Novo Nordisk for $200 million By Investing.com
Edgestream Partners L.P. Acquires New Holdings in Novavax, Inc. (NASDAQ:NVAX)
Novavax sells Czech manufacturing facility to Novo Nordisk for $200 mln By Investing.com
Edgestream Partners L.P. Makes New Investment in Novavax, Inc. (NASDAQ:NVAX)
Novavax Rallies on Sale of Czech Facility to Novo Nordisk (1)
Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 mln
Novavax To Sell Manufacturing Facility In Bohumil, Czech Republic To Novo Nordisk For $200 Mln
Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200 Million | Morningstar
Novavax sells Czech manufacturing facility to Novo Nordisk for $200 mn | World News - Business Standard
Bank of Montreal Can Purchases 517,727 Shares of Novavax, Inc. (NASDAQ:NVAX)
Novavax, Inc. (NASDAQ:NVAX) Given Average Rating of “Hold” by Brokerages
Novavax, Inc. (NASDAQ:NVAX) Receives Average Rating of "Hold" from Analysts
Novavax and Assembly lead infectious disease gainers in 2024 | BioWorld
